Evidence map›Paper›PMID 21502320›Full record

ArticleThe Journal of biological chemistry2011

The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.

Sujata Balasubramanian, Meiyun Fan, Angela F Messmer-Blust, Chuan H Yang, Jill A Trendel, Jonathan A Jeyaratnam, Lawrence M Pfeffer, Deborah J Vestal

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2016
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Taurine Reverses Atrial Structural Remodeling in Ach-CaclAdvances in experimental medicine and biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sujata BalasubramanianDepartment of Biological Sciences, University of Toledo, Toledo, Ohio 43606, USA.
Meiyun Fan
Angela F Messmer-Blust
Chuan H Yang
Jill A Trendel
Jonathan A Jeyaratnam
Lawrence M Pfeffer
Deborah J Vestal
University of Toledo · USUniversity of Tennessee Health Science Center · US

Funding

IFNARI SIGNALING THROUGH STAT3, PI 3 KINASER01CA073753 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI PFEFFER, LAWRENCE MARC · 1998 to 2007
$2.4M
Molecular mechanism of ID1 function in advanced breast cancerR01CA140346 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI FAN, MEIYUN · 2009 to 2013
$1.2M
NCI NIH HHS CA73753NCI NIH HHS R01 CA073753NCI NIH HHS R01 CA140346
6 · The paper itself

Abstract

Matrix metalloproteinase-9 (MMP-9) is important in numerous normal and pathological processes, including the angiogenic switch during tumor development and tumor metastasis. Whereas TNF-α and other cytokines up-regulate MMP-9 expression, interferons (IFNs) inhibit MMP-9 expression. We found that IFN-γ treatment or forced expression of the IFN-induced GTPase, mGBP-2, inhibit TNF-α-induced MMP-9 expression in NIH 3T3 fibroblasts, by inhibiting MMP-9 transcription. The NF-κB transcription factor is required for full induction of MMP-9 by TNF-α. Both IFN-γ and mGBP-2 inhibit the transcription of a NF-κB-dependent reporter construct, suggesting that mGBP-2 inhibits MMP-9 induction via inhibition of NF-κB-mediated transcription. Interestingly, mGBP-2 does not inhibit TNF-α-induced degradation of IκBα or p65/RelA translocation into the nucleus. However, mGBP-2 inhibits p65 binding to a κB oligonucleotide probe in gel shift assays and to the MMP-9 promoter in chromatin immunoprecipitation assays. In addition, TNF-α activation of NF-κB in NIH 3T3 cells is dependent on Rac activation, as evidenced by the inhibition of TNF-α induction of NF-κB-mediated transcription by a dominant inhibitory form of Rac1. A role for Rac in the inhibitory action of mGBP-2 on NF-κB is further shown by the findings that mGBP-2 inhibits TNF-α activation of endogenous Rac and constitutively activate Rac can restore NF-κB transcription in the presence of mGBP-2. This is a novel mechanism by which IFNs can inhibit the cytokine induction of MMP-9 expression.

Indexed as

Active Transport, Cell NucleusAnimalsAntiviral AgentsCell NucleusEnzyme InductionFibroblastsGTP-Binding ProteinsI-kappa B ProteinsInterferon-gammaMatrix Metalloproteinase 9MiceNeuropeptidesNF-KappaB Inhibitor alphaNIH 3T3 Cellsrac1 GTP-Binding Proteinrac GTP-Binding ProteinsAntiviral AgentsGbp2 protein, mouseGTP-Binding ProteinsI-kappa B ProteinsInterferon-gammaMatrix Metalloproteinase 9Mmp9 protein, mouseNeuropeptidesNF-KappaB Inhibitor alphaNfkbia protein, mouserac1 GTP-Binding ProteinRac1 protein, mouserac GTP-Binding ProteinsRela protein, mouseTranscription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID21502320
PMCPMC3103378
OpenAlexW1969479370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.